• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000388 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Supplementary Application 2020-08-21 Sanofi-aventis groupe Sanofi-Aventis Groupe;Sanofi Winthrop Industrie Filed 2020-09-02 view
JXSS2000035 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2020-09-30 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe;Sanofi Winthrop Industrie Certificate Issued 2021-09-10 view
JXSS2000034 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2020-09-30 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe;Sanofi Winthrop Industrie Certificate Issued 2021-09-10 view
JXSL2000177 度普利尤单抗注射液 dupilumab Injection Biological Products(2.2) Import Drug Application 2020-10-14 Sanofi-aventis recherche & développement Sanofi-Aventis Recherche & Developpement In Review 2020-10-12 view
JXSL2000176 度普利尤单抗注射液 dupilumab Injection Biological Products(2.2) Import Drug Application 2020-10-14 Sanofi-aventis recherche & développement Sanofi-Aventis Recherche & Developpement In Review 2020-10-12 view
JXSL2000189 度普利尤单抗注射液 dupilumab Injection Biological Products(2.2) Import Drug Application 2020-10-27 Sanofi-aventis recherche & développement Sanofi-Aventis Recherche & Developpement In Review 2020-10-23 view
JXSL2000190 度普利尤单抗注射液 dupilumab Injection Biological Products(2.2) Import Drug Application 2020-10-27 Sanofi-aventis recherche & développement Sanofi-Aventis Recherche & Developpement In Review 2020-10-23 view
JYSB2000683 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Supplementary Application 2021-01-01 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe;Sanofi Winthrop Industrie Certificate Issued 2021-09-22 view
JXSS2101005 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2021-05-10 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JXSS2101006 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2021-05-10 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JXSL2101140 度普利尤单抗注射液 dupilumab Injection Biological Products(2.2) Import Drug Application 2021-11-30 Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement view
JYSB2200080 度普利尤单抗注射液 dupilumab Injection Biological Products Supplementary Application 2022-05-07 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
JYSB2200081 度普利尤单抗注射液 dupilumab Injection Biological Products Supplementary Application 2022-05-07 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
JYSB2200175 度普利尤单抗注射液 dupilumab Injection Biological Products Supplementary Application 2022-09-09 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
JYSB2200174 度普利尤单抗注射液 dupilumab Injection Biological Products Supplementary Application 2022-09-09 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
JYSB2200207 度普利尤单抗注射液 dupilumab Injection Biological Products Supplementary Application 2022-10-22 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
JYSB2200208 度普利尤单抗注射液 dupilumab Injection Biological Products Supplementary Application 2022-10-22 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
JXSL2200187 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2022-10-27 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd view
JXSS2300010 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2023-01-12 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JXSS2300007 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Import Drug Application 2023-01-12 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view